Dysregulation of the SATB1‐MIR22‐GBA pathway, observed in both PD patients and normal aging, leads to lysosomal and mitochondrial dysfunction due to the GluCer accumulation, ultimately resulting in a cellular senescence‐like phenotype in dopaminergic neurons. Here, SATB1 is linked to Parkinson disease.